218 related articles for article (PubMed ID: 23443810)
1. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-30c promotes renal fibrosis by target CTGF in diabetic nephropathy.
Wang J; Duan L; Guo T; Gao Y; Tian L; Liu J; Wang S; Yang J
J Diabetes Complications; 2016 Apr; 30(3):406-14. PubMed ID: 26775556
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice.
Wang J; Duan L; Gao Y; Zhou S; Liu Y; Wei S; An S; Liu J; Tian L; Wang S
Mol Cell Endocrinol; 2018 Sep; 472():149-158. PubMed ID: 29233785
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
5. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.
Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J
Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121
[TBL] [Abstract][Full Text] [Related]
8. miR-21 is a critical therapeutic target for renal fibrosis.
He Y; Huang C; Li J
Cell Biochem Biophys; 2014 Apr; 68(3):635-6. PubMed ID: 24126704
[No Abstract] [Full Text] [Related]
9. miR-17 targets tissue inhibitor of metalloproteinase 1 and 2 to modulate cardiac matrix remodeling.
Li SH; Guo J; Wu J; Sun Z; Han M; Shan SW; Deng Z; Yang BB; Weisel RD; Li RK
FASEB J; 2013 Oct; 27(10):4254-65. PubMed ID: 23825222
[TBL] [Abstract][Full Text] [Related]
10. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
Zhang S; Xu L; Liang R; Yang C; Wang P
J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
[TBL] [Abstract][Full Text] [Related]
11. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
12. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
Sun H; Ge N; Shao M; Cheng X; Li Y; Li S; Shen J
Diabetes Res Clin Pract; 2013 Apr; 100(1):85-95. PubMed ID: 23384615
[TBL] [Abstract][Full Text] [Related]
13. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
[TBL] [Abstract][Full Text] [Related]
14. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.
Fiorentino L; Cavalera M; Mavilio M; Conserva F; Menghini R; Gesualdo L; Federici M
Acta Diabetol; 2013 Dec; 50(6):965-9. PubMed ID: 23797704
[TBL] [Abstract][Full Text] [Related]
15. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1.
He F; Peng F; Xia X; Zhao C; Luo Q; Guan W; Li Z; Yu X; Huang F
Diabetologia; 2014 Aug; 57(8):1726-36. PubMed ID: 24908566
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy.
Zhao B; Li H; Liu J; Han P; Zhang C; Bai H; Yuan X; Wang X; Li L; Ma H; Jin X; Chu Y
J Am Soc Nephrol; 2016 Sep; 27(9):2597-608. PubMed ID: 26839366
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
[TBL] [Abstract][Full Text] [Related]
18. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
[TBL] [Abstract][Full Text] [Related]
19. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
